Protocol Labs vs Altria

Side-by-side comparison of AI visibility scores, market position, and capabilities

Altria leads in AI visibility (90 vs 30)

Protocol Labs

EmergingFintech

General

Protocol Labs is a research and development organization building the decentralized web, behind foundational technologies including IPFS, Filecoin, libp2p, and the IPLD data model.

AI VisibilityBeta
Overall Score
D30
Category Rank
#1162 of 1167
AI Consensus
75%
Trend
stable
Per Platform
ChatGPT
26
Perplexity
31
Gemini
31

About

Protocol Labs is a distributed research, development, and deployment organization focused on building the protocols and infrastructure of the decentralized internet. Founded by Juan Benet in 2014, the company has developed some of the most widely used open-source protocols in the web3 ecosystem, including IPFS (InterPlanetary File System), a peer-to-peer hypermedia protocol that enables decentralized content-addressed storage; Filecoin, a decentralized storage network with a cryptocurrency incentive layer; and libp2p, a modular network stack used by Ethereum, Polkadot, and numerous other blockchain projects.

Full profile

Altria

LeaderConsumer Goods

Enterprise

Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.

AI VisibilityBeta
Overall Score
A90
Category Rank
#83 of 290
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
84
Perplexity
97
Gemini
99

About

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.

Full profile

AI Visibility Head-to-Head

30
Overall Score
90
#1162
Category Rank
#83
75
AI Consensus
58
stable
Trend
stable
26
ChatGPT
84
31
Perplexity
97
31
Gemini
99
21
Claude
86
27
Grok
87

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.